• Newsletters
  • Gift Membership
Logo Logo
Take Scroll With You Download the app to read our award-winning journalism on the go and stay up-to-date with our notifications.
Get the app Get the app
ANDROID iOS
  • Home
  • Common Ground
  • The India Fix
  • Eco India
  • The Latest
  • The Reel
  • Magazine
  • Video
  • Trending
    • The Congolese philosopher who liberated ‘Africa’ from the chains of Western thought
    • Four questions Indians must ask about Operation Sindoor
    • A new book examines the repercussions of shutting the Indian Railways network during Covid-19
    • Interview: US claiming credit for ceasefire sets Indian foreign policy back by decades
    • Fiction: Payal agrees to marry an Ukrainian mafia boss’s son after escaping an attempt on her life
    • In Manipur, Kuki-Zo women are protesting customary ‘settlement’ of rape, domestic violence cases
    • Why India’s censorship of news media online without stating reasons is unlawful
    • Why the India-Pakistan ceasefire is giving Modi supporters heartburn
    • Pakistan claims 40 civilians, 11 military personnel killed in conflict with India
    • Interview: ‘Op Sindoor won't stop terror; conflict with India existential for Pak Army’
    • ‘A period of transformation’: Why Marathi film ‘April May 99’ couldn’t have been set in another year
    • Operation Sindoor: Both Hindutva backers and leftists are wrong in claiming India-Israel parallels
  • Sections
    • Politics
    • Culture
    • India
    • World
    • Film and TV
    • Music
    • Books and Ideas
    • Business and Economy
    • Science and Technology
    • In Pictures
    • Announcements
    • Bookshop
    • The Field
    • Pulse
    • Elections 2024

covid-19 medicine

  • A new antibody treatment may offer protection against severe Covid-19 for up to 18 months

    A new antibody treatment may offer protection against severe Covid-19 for up to 18 months

    Rebecca Aicheler, The Conversation
    · Oct 22, 2021 · 11:30 pm
  • A new oral antiviral drug for Covid-19 is moving into the final stages of testing in humans

    A new oral antiviral drug for Covid-19 is moving into the final stages of testing in humans

    Filipa Henderson Sousa, The Conversation Peter Barlow, The Conversation
    · Oct 07, 2021 · 07:30 pm
  • A simple pill to beat Covid-19? It sounds too good to be true, but Pfizer is giving it a go

    A simple pill to beat Covid-19? It sounds too good to be true, but Pfizer is giving it a go

    Peter Wark, The Conversation
    · Jun 02, 2021 · 07:30 pm
  • Will a vaccine and herd immunity really end the coronavirus pandemic?

    Will a vaccine and herd immunity really end the coronavirus pandemic?

    Nigel McMillan, The Conversation
    · Jul 18, 2020 · 07:30 pm
  • Coronavirus: Health ministry revises dosage of anti-viral drug remdesivir for Covid-19 patients

    Coronavirus: Health ministry revises dosage of anti-viral drug remdesivir for Covid-19 patients

    Scroll Staff
    · Jul 04, 2020 · 03:02 pm
  • How will newly-approved antiviral drugs help in the fight against Covid-19? An internist explains

    How will newly-approved antiviral drugs help in the fight against Covid-19? An internist explains

    Govindraj Ethiraj, IndiaSpend.com
    · Jun 30, 2020 · 09:30 pm
  • What are the steps of vaccine development? And what do they mean?

    What are the steps of vaccine development? And what do they mean?

    Mindy Aisen, The Conversation
    · Jun 09, 2020 · 11:30 pm
  • What is a cytokine storm? And why is its prevention key to treating Covid-19?

    What is a cytokine storm? And why is its prevention key to treating Covid-19?

    Alexander (Sasha) Poltorak, The Conversation
    · May 23, 2020 · 08:30 pm
  • On India’s Covid-19 frontline, differently-abled medics are facing greater health risks

    On India’s Covid-19 frontline, differently-abled medics are facing greater health risks

    Priti Salian, qz.com
    · May 12, 2020 · 08:30 pm